Ojaskara Medicament Private Limited

Ojaskara Medicament Private Limited - trading in Rairangpur, Orissa, India. FY 2026 financials and compliance.
CIN U51909OR2019PTC031523 Incorporated 19 August 2019 ROC Cuttack HQ Rairangpur, Orissa, India
Active Private Limited Company trading
Data last updated
Revenue · FY 2024
₹33.17 Lakh
▲ 51.00% YoY
EBITDA · FY 2024
*****
▲ 640.00% YoY
Net profit · FY 2024
*****
▲ 694.00% YoY
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹3 Lakh
Issued & subscribed
Open charges
None
Secured borrowings
Company age
7 yrs
Est. 2019
Last financials
Mar 2025
Balance sheet date

About Ojaskara Medicament Private Limited

Data last updated: 21 February 2026

Ojaskara Medicament Private Limited is a private limited company based in Rairangpur, Orissa, India. It specialises in specialised services, a part of the broader trading and commerce sector. Incorporated on 19 August 2019, the company has been in operation for over 7 years.

Registered with ROC Cuttack under CIN U51909OR2019PTC031523.

Capital: an authorised share capital of ₹10 Lakh and a paid-up capital of ₹3 Lakh. It is led by directors including Arvind Agarwal and Ajit Kumar Mishra.

Last AGM: 30 September 2025. Financial statements filed for year ended 31 March 2025. Office: C/O. Arun Kumar Agarwal Ward No.15 Link Road Control Shop, Rairangpur, Orissa, India – 757043.

As per the financials filed for FY 2024, the company reported a revenue of ₹33.17 Lakh, a growth of 51% compared to the previous year.

Company Details of Ojaskara Medicament Private Limited
CIN U51909OR2019PTC031523
Registration Number 031523
Incorporation Date 19 August 2019
ROC Cuttack
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Key People
Arvind Agarwal Director Ajit Kumar Mishra Director Sunita Agrawal Director
Contact Details
  • Email
    *****@*****.com
  • Telephone
    **************
  • Website
    **************
  • Social Media
    **************
  • Registered Address
    C/O. Arun Kumar Agarwal Ward No.15 Link Road Control Shop, Rairangpur, Orissa, India – 757043
  • Industry
    Trading, Specialty, Wholesale
Company report
Ojaskara Medicament Private Limited - full intelligence report
  • Historical Financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Litigation, compliance and MCA filings
  • PDF report delivered after checkout
₹799 ₹999 20% off
Secure checkout · GST invoice included

Unlock the full Ojaskara Medicament Private Limited report

Financials, compliance, directors, charges, ownership and filings for Ojaskara Medicament Private Limited in one report.

10-year financials Directors & ownership Charges & compliance

Business Activity of Ojaskara Medicament Private Limited

Ojaskara Medicament Private Limited is engaged in the principal business activity of trade, with detailed activities including wholesale trading.

Main Activity Group Code Description of Main Activity Business Activity Code Description of Business Activity Turnover Percentage
G Trade G1 Wholesale Trading *********

Board of Directors of Ojaskara Medicament Private Limited

Ojaskara Medicament Private Limited is currently managed by 4 directors, with 1 former director having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.

Current Directors
Name Designation Appointment Date Tenure Status
Arvind Agarwal Director 19 Aug 2019 6 Years 10 Months Current
Ajit Kumar Mishra Director 19 Aug 2019 6 Years 10 Months Current
Sunita Agrawal Director 19 Aug 2019 6 Years 10 Months Current
Rakesh Kumar Tiwary Additional Director 15 May 2021 5 Years 1 Months Current
View all directors

Financials of Ojaskara Medicament Private Limited FY 2025 filings available

Ojaskara Medicament Private Limited reported revenue of ₹33.17 Lakh (up 51% YoY) for FY 2024. Profit growth despite declining revenue indicates effective cost management and margin discipline.

Revenue
₹33.17 Lakh ▲ 51%
Profit
***** ▲ 694%
EBITDA
***** ▲ 640%
Metrics
*****
*****
*****
*****
*****
Revenue
Revenue from Operations
*****
*****
*****
*****
*****
Revenue Growth %
*****
*****
*****
*****
*****
Other Income
*****
*****
*****
*****
*****
Total Revenue
*****
*****
*****
*****
*****
Expenses
Total Expenses
*****
*****
*****
*****
*****
Raw Material Cost
*****
*****
*****
*****
*****
Change in Inventory FG
*****
*****
*****
*****
*****
Change in Inventory WIP
*****
*****
*****
*****
*****
Purchase of Traded Goods
*****
*****
*****
*****
*****
Employee Cost
*****
*****
*****
*****
*****
Managerial Remuneration
*****
*****
*****
*****
*****
Audit Fees
*****
*****
*****
*****
*****
Insurance
*****
*****
*****
*****
*****
Power & Fuel
*****
*****
*****
*****
*****
Interest
*****
*****
*****
*****
*****
Depreciation
*****
*****
*****
*****
*****
Other Expenses
*****
*****
*****
*****
*****
Profitability
EBITDA (Operating Profit)
*****
*****
*****
*****
*****
Operating Margin %
*****
*****
*****
*****
*****
Exceptional Items
*****
*****
*****
*****
*****
Extraordinary Items
*****
*****
*****
*****
*****
Profit Before Exceptional & Extraordinary Items
*****
*****
*****
*****
*****
Profit Before Tax
*****
*****
*****
*****
*****
Tax & Net Profit
Tax Expense
*****
*****
*****
*****
*****
Current Tax
*****
*****
*****
*****
*****
Deferred Tax
*****
*****
*****
*****
*****
Profit from Discontinued Operations
*****
*****
*****
*****
*****
Tax on Discontinued Operations
*****
*****
*****
*****
*****
Profit
*****
*****
*****
*****
*****
Net Margin %
*****
*****
*****
*****
*****
Metrics
*****
*****
*****
*****
*****
Shareholders' Funds
Total Shareholders' Funds
*****
*****
*****
*****
*****
Equity Capital
*****
*****
*****
*****
*****
Reserves & Surplus
*****
*****
*****
*****
*****
Money Against Warrants
*****
*****
*****
*****
*****
Other Equity
*****
*****
*****
*****
*****
Non-Current Liabilities
Total Non-Current Liabilities
*****
*****
*****
*****
*****
Long-Term Borrowings
*****
*****
*****
*****
*****
Deferred Tax Liabilities
*****
*****
*****
*****
*****
Other Non-Current Liabilities
*****
*****
*****
*****
*****
Long-Term Provisions
*****
*****
*****
*****
*****
Current Liabilities
Total Current Liabilities
*****
*****
*****
*****
*****
Short-Term Borrowings
*****
*****
*****
*****
*****
Trade Payables
*****
*****
*****
*****
*****
Other Current Liabilities
*****
*****
*****
*****
*****
Short-Term Provisions
*****
*****
*****
*****
*****
Total Equity & Liabilities
*****
*****
*****
*****
*****
Non-Current Assets
Non-Current Assets
*****
*****
*****
*****
*****
Tangible Assets
*****
*****
*****
*****
*****
Intangible Assets
*****
*****
*****
*****
*****
Capital WIP
*****
*****
*****
*****
*****
Intangibles Under Dev
*****
*****
*****
*****
*****
Investments
*****
*****
*****
*****
*****
Deferred Tax Assets
*****
*****
*****
*****
*****
LT Loans & Advances
*****
*****
*****
*****
*****
Other Non-Current Assets
*****
*****
*****
*****
*****
Current Assets
Current Assets
*****
*****
*****
*****
*****
Current Investments
*****
*****
*****
*****
*****
Inventories
*****
*****
*****
*****
*****
Trade Receivables
*****
*****
*****
*****
*****
Cash & Bank Balance
*****
*****
*****
*****
*****
ST Loans & Advances
*****
*****
*****
*****
*****
Other Current Assets
*****
*****
*****
*****
*****
Total Assets
*****
*****
*****
*****
*****
Metrics
*****
*****
*****
*****
*****
Cash from Operating Activities (CFO)
Profit Before Tax
*****
*****
*****
*****
*****
Non-Cash Adjustments
*****
*****
*****
*****
*****
+ Interest Expense
*****
*****
*****
*****
*****
+ Depreciation
*****
*****
*****
*****
*****
+/- Unrealized Forex
*****
*****
*****
*****
*****
- Dividend Income
*****
*****
*****
*****
*****
- Interest Income
*****
*****
*****
*****
*****
+/- Other Non-Cash Items
*****
*****
*****
*****
*****
Changes in Working Capital
*****
*****
*****
*****
*****
+/- Inventory
*****
*****
*****
*****
*****
+/- Debtors
*****
*****
*****
*****
*****
+/- Creditors
*****
*****
*****
*****
*****
Reconciliation Adjustments
*****
*****
*****
*****
*****
Cash Generated from Operations
*****
*****
*****
*****
*****
Income Taxes Paid
*****
*****
*****
*****
*****
Net CFO (Cash from Operations)
*****
*****
*****
*****
*****
Cash from Investing Activities (CFI)
Acquisitions & Disposals
*****
*****
*****
*****
*****
Disposal of Subsidiaries
*****
*****
*****
*****
*****
Acquisition of Subsidiaries
*****
*****
*****
*****
*****
Capex
*****
*****
*****
*****
*****
Purchase of Fixed Assets
*****
*****
*****
*****
*****
Sale of Fixed Assets
*****
*****
*****
*****
*****
Other Investing Cash Flows
*****
*****
*****
*****
*****
Net CFI (Cash from Investing)
*****
*****
*****
*****
*****
Cash from Financing Activities (CFF)
Equity Issuance
*****
*****
*****
*****
*****
Debt Raised
*****
*****
*****
*****
*****
Debt Repaid
*****
*****
*****
*****
*****
Dividends Paid
*****
*****
*****
*****
*****
Interest Paid
*****
*****
*****
*****
*****
Net CFF (Cash from Financing)
*****
*****
*****
*****
*****
Net Cash Position
Net Change in Cash (Pre-Forex)
*****
*****
*****
*****
*****
Closing Cash & Equivalents
*****
*****
*****
*****
*****
Metrics
*****
*****
*****
*****
*****
Liquidity
Current Ratio
*****
*****
*****
*****
*****
Quick Ratio
*****
*****
*****
*****
*****
Cash Ratio
*****
*****
*****
*****
*****
Efficiency
Inventory Days
*****
*****
*****
*****
*****
Debtor Days
*****
*****
*****
*****
*****
Creditor Days
*****
*****
*****
*****
*****
Cash Conversion Cycle
*****
*****
*****
*****
*****
Asset Turnover
*****
*****
*****
*****
*****
Profitability
Net Profit Margin %
*****
*****
*****
*****
*****
Operating Margin %
*****
*****
*****
*****
*****
ROE %
*****
*****
*****
*****
*****
ROCE %
*****
*****
*****
*****
*****
Net Worth Margin %
*****
*****
*****
*****
*****
Growth
Revenue Growth %
*****
*****
*****
*****
*****
Leverage
Equity Multiplier
*****
*****
*****
*****
*****
Debt / EBITDA
*****
*****
*****
*****
*****
Solvency
D/E Ratio
*****
*****
*****
*****
*****
ICR
*****
*****
*****
*****
*****

Consolidated Statements

Income Statement, Balance Sheet, Cash Flow & Ratios available in the full report.

Unlock Complete Financial History (FY 2015 – Latest)
Standalone & Consolidated - Income Statement, Balance Sheet, Cash Flow, Financial Ratios and Growth Trends with 10+ years of line-item data.
10+ years of data Line-item breakdown Balance Sheet detail Cash Flow analysis 20+ ratios & metrics Downloadable PDF
What Is the Ownership and Shareholding Structure of Ojaskara Medicament Private Limited?

View Ojaskara Medicament Private Limited's control and ownership data: shareholding patterns, funding details, FII information, directors and KMP remuneration, group structure, overseas investment and related data.

Shareholding Pattern (FY 2026)
Shareholding pattern chart
  • Promoters: **.**%
  • Public: **.**%
  • Others: **.**%
Shareholding Pattern over the Year
FY 2026 FY 2025 FY 2024 FY 2023 FY 2022
Promoters**.****.****.****.****.**
Public**.****.****.****.****.**
Others**.****.****.****.****.**

Full shareholding pattern with quarterly trends.

Charges & Borrowings Ojaskara Medicament Private Limited

Ojaskara Medicament Private Limited does not have any charges (loans) registered with the Registrar of Companies.

Employees and EPFO Compliance at Ojaskara Medicament Private Limited

View historical data on people associated with Ojaskara Medicament Private Limited, including employment history and EPFO contributions.

2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026

Employee Count & EPFO Data of Ojaskara Medicament Private Limited

Access employee headcount trends, monthly PF payment records, EPFO establishment details, and compliance data.

Monthly employee headcount & PF contributions
EPFO establishment details & ECR filing status
Year-wise workforce analytics & attrition trends
PF exemption, coverage & compliance verification

GST Compliance of Ojaskara Medicament Private Limited

XX%
Compliant
GSTR-1
GSTR-3B
GSTR-9
MH
KA
UP
TN
TS

GSTIN & GST Filing Data of Ojaskara Medicament Private Limited

Access GSTIN registrations, state-wise filing compliance, HSN/SAC codes, and detailed goods & services data.

GSTIN registrations & state-wise presence
Filing compliance - GSTR-1, GSTR-3B, GSTR-9
HSN/SAC codes with goods & services details
Taxpayer type, jurisdiction & business constitution

Credit Ratings, Litigation & Regulatory Alerts for Ojaskara Medicament Private Limited

Credit rating
AAA
AA+
AA
AA-
! !
2015 2017 2019 2021 2023
Litigation
District Court 35
High Court 45
Supreme Court 0
NCLT / NCLAT 0
Pending
Disposed
Regulatory alerts
GSTIN Cancelled
Andhra Pradesh
GSTIN Cancelled
Telangana (on application)
EPFO Delay
12 months delay - Haryana
Violations via Directors
20 MCA + 19 Bank defaults

Credit Ratings, Legal Cases & Regulatory Alerts of Ojaskara Medicament Private Limited

Access complete credit rating history, litigation records, regulatory alerts, and compliance data.

Credit rating history across CARE, ICRA, Brickwork & India Ratings
Instrument-wise ratings, outlook & action timeline
Court-wise litigation (District, High Court, Supreme Court, NCLT)
Group company & common directorship litigation
Statutory compliance alerts (GSTIN, EPFO, ROC)
Director & company violations (MCA, SEBI, Banks, BSE/NSE)

MSME Payment Delays by Ojaskara Medicament Private Limited

MSME Payment Delays by Ojaskara Medicament Private Limited

Track payments outstanding to micro and small enterprise vendors, as disclosed in half-yearly MSME-1 returns filed with the MCA.

Amounts outstanding to MSME suppliers
Delay periods & reasons for delayed payments
Half-yearly MSME-1 filing history
Vendor-payment behaviour as a counterparty risk signal

Subsidiaries & Group Companies of Ojaskara Medicament Private Limited

Subsidiaries & Group Companies of Ojaskara Medicament Private Limited

See the full corporate group - holding company, subsidiaries, associates and joint ventures of Ojaskara Medicament Private Limited with ownership details.

Holding & parent company details
Subsidiaries & step-down subsidiaries with % holding
Associates & joint ventures with partner details
Investments in other entities year-on-year

MCA Filings & Documents of Ojaskara Medicament Private Limited

MCA Filings & Documents of Ojaskara Medicament Private Limited

Download official documents filed with the Ministry of Corporate Affairs - from incorporation papers to the latest annual filings.

Incorporation documents, MoA & AoA
Annual returns (MGT-7) & financial statements (AOC-4)
Charge filings (CHG-1, CHG-4) & resolutions
Complete document index with filing dates

Recent Activity on Ojaskara Medicament Private Limited

Activity
30 Sep 2025
Ojaskara Medicament Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Activity
31 Mar 2025
Ojaskara Medicament Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Cuttack.
Directors
15 May 2021
Rakesh Kumar Tiwary was appointed as a Additional Director on 15 May 2021 & has been associated with this company since 5 years 1 month.
Directors
19 Aug 2019
Arvind Agarwal was appointed as a Director on 19 Aug 2019 & has been associated with this company since 6 years 10 months.
Directors
19 Aug 2019
Ajit Kumar Mishra was appointed as a Director on 19 Aug 2019 & has been associated with this company since 6 years 10 months.
Directors
19 Aug 2019
Sunita Agrawal was appointed as a Director on 19 Aug 2019 & has been associated with this company since 6 years 10 months.

Frequently Asked Questions about Ojaskara Medicament Private Limited

Ojaskara Medicament Private Limited is an active private limited company in the trading sector based in Rairangpur, Orissa, India. It was incorporated on 19 August 2019 (7+ years old) and is registered under CIN U51909OR2019PTC031523.

Ojaskara Medicament Private Limited reported revenue of ₹33.17 Lakh for FY 2024 (up 51.00% YoY).

The current directors of Ojaskara Medicament Private Limited are:

The primary industry of Ojaskara Medicament Private Limited is trading. The company specifically operates in specialty. The company is currently active in this sector.

Ojaskara Medicament Private Limited can be reached at the registered office: CO. Arun Kumar Agarwal Ward No.15 Link Road Control Shop, Rairangpur, Orissa, India – 757043.

The authorised capital is ₹10 Lakh, and the paid-up capital is ₹3 Lakh.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - sourced from MCA, SEBI and RBI filings.

Subscription plans available